Delving into the Latest Updates on Aixintong Tablets with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Nervous System DiseasesCardiovascular Diseases

Active Indication

Angina PectorisCoronary Artery Disease

Inactive Indication-

Originator Organization

Shenzhen Neptunus Pharmaceutical Co. Ltd.

Active Organization

Shenzhen Neptunus Pharmaceutical Co. Ltd.

Inactive Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

On the basis of the Phase IIa clinical trial, we will further explore the effectiveness and safety of Aixintong Tablets in the treatment of angina pectoris (cardiac blood stasis syndrome) of coronary heart disease, and conduct dose exploration to provide a basis for the design of Phase III confirmatory clinical trials.

Start Date04 Sep 2013

Sponsor / Collaborator

Shenzhen Neptunus Pharmaceutical Co. Ltd.

100 Clinical Results associated with Aixintong Tablets

Login to view more data

100 Translational Medicine associated with Aixintong Tablets

Login to view more data

100 Patents (Medical) associated with Aixintong Tablets

Login to view more data

100 Deals associated with Aixintong Tablets

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Angina Pectoris	Phase 2	CN	Shenzhen Neptunus Pharmaceutical Co. Ltd.	04 Sep 2013
Coronary Artery Disease	Phase 2	CN	Shenzhen Neptunus Pharmaceutical Co. Ltd.	04 Sep 2013